These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7240742)

  • 1. The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells.
    Adams DO; Pike MC; Snyderman R
    J Immunol; 1981 Jul; 127(1):225-30. PubMed ID: 7240742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
    Adams DO; Marino PA; Meltzer MS
    J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
    Somers SD; Mastin JP; Adams DO
    J Immunol; 1983 Oct; 131(4):2086-93. PubMed ID: 6413586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.
    Adams DO
    J Immunol; 1980 Jan; 124(1):286-92. PubMed ID: 6985641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
    Somers SD; Whisnant CC; Adams DO
    J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
    Viadro MM
    Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between competence for secretion of H2O2 and completion of tumor cytotoxicity by BCG-elicited murine macrophages.
    Cohen MS; Taffet SM; Adams DO
    J Immunol; 1982 Apr; 128(4):1781-5. PubMed ID: 7061849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen peroxide and cytolytic factor can interact synergistically in effecting cytolysis of neoplastic targets.
    Adams DO; Johnson WJ; Fiorito E; Nathan CF
    J Immunol; 1981 Nov; 127(5):1973-7. PubMed ID: 7299120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cytolytic function of mononuclear phagocytes. II. Factors that determine the binding and lysis of tumor cells by activated macrophages].
    Vasil'ev VIu; Krotkova MV; Popova EV; Shatrova AN
    Tsitologiia; 1990; 32(3):275-81. PubMed ID: 2219450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression.
    Wu QL; Fu YF; Zhou WL; Wang JX; Feng YH; Liu J; Xu JY; He PL; Zhou R; Tang W; Wang GF; Zhou Y; Yang YF; Ding J; Li XY; Chen XR; Yuan C; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2005 May; 313(2):705-11. PubMed ID: 15640397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells.
    Marino PA; Whisnant CC; Adams DO
    J Exp Med; 1981 Jul; 154(1):77-87. PubMed ID: 6788893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD; Yoon HJ; Kim HM; Chung HT
    Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
    Gray JD; Brooks CG; Baldwin RW
    Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver macrophage-mediated cytotoxicity toward mastocytoma cells involves phagocytosis of tumor targets.
    Gardner CR; Wasserman AJ; Laskin DL
    Hepatology; 1991 Aug; 14(2):318-24. PubMed ID: 1907256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
    No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL; Perera PY; Salkowski CA; Vogel SN
    J Immunol; 1994 Jan; 152(2):825-31. PubMed ID: 7506736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.
    Adams DO; Marino PA
    J Immunol; 1981 Mar; 126(3):981-7. PubMed ID: 7007505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.